Kelch样环氧氯丙烷相关蛋白-1-核因子E2相关因子2/抗氧化反应元件抗氧化应激通路在多发性硬化中作用的研究进展

doi:10.3969/j.issn.1006-9771.2020.03.013

Abstract

Abstract:

Multiple sclerosis (MS) is a chronic inflammatory disease, mainly due to the activation of the T cells, which makes oxidative stress reaction in brain and leads to demyelination finally. Kelch-like ECH-associated protein-1 (Keap1)-nuclear factor erythroid 2-related factor-2 (Nrf2)/antioxidant responsive element (ARE) signal pathway is one of the most important endogenous antioxidant pathways, which promotes the expression of detoxification enzymes and antioxidant protein to eliminate oxygen free radicals and balance intracellular redox system. Activation of the Keap1-Nrf2/ARE may delay the progression of MS by drugs or rehabilitation.

Key words: multiple sclerosis, oxidative stress, Kelch-like ECH-associated protein-1, nuclear factor E2-related factor-2, antioxidant responsive element, signal pathway, review

CLC Number:

R744.5

SU Ling-ling,ZHENG Bi-e,HE Jin-di,FAN Jian-zhong,YIN Rui-xue. Role of Kelch-like ECH-associated Protein-1-Nuclear Factor Erythroid 2-related Factor-2/Antioxidant Responsive Element Signal Pathway for Multiple Sclerosis (review)[J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2020, 26(3): 330-333.

References 47

[1]	Sánchez-López A L, Ortiz G G, Pacheco-Moises F P, et al. Efficacy of melatonin on serum pro-inflammatory cytokines and oxidative stress markers in relapsing remitting multiple sclerosis[J]. Arch Med Res, 2018, 49(6):391-398. doi: S0188-4409(18)30551-4 pmid: 30595364
[2]	Glass C K, Saijo K, Winner B, et al. Mechanisms underlying inflammation in neurodegeneration[J]. Cell, 2010, 140(6):918-934. doi: 10.1016/j.cell.2010.02.016
[3]	Harrison K. Fingolimod for multiple sclerosis: a review for the specialist nurse[J]. Br J Nurs, 2014, 23(11):582-589. pmid: 24933548
[4]	Ohl K, Tenbrock K, Kipp M. Oxidative stress in multiple sclerosis: central and peripheral mode of action[J]. Exp Neurol, 2016, 277:58-67. doi: 10.1016/j.expneurol.2015.11.010
[5]	Compston A, Coles A. Multiple sclerosis[J]. Lancet, 2008, 372(9648):1502-1517. doi: 10.1016/S0140-6736(08)61620-7
[6]	Lim J L, Wilhelmus M M, de Vries H E, et al. Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases[J]. Arch Toxicol, 2014, 88(10):1773-1786. doi: 10.1007/s00204-014-1338-z
[7]	Feinstein A, Freeman J, Lo A C. Treatment of progressive multiple sclerosis: what works, what does not, and what is needed[J]. Lancet Neurol, 2015, 14(2):194-207. doi: 10.1016/S1474-4422(14)70231-5 pmid: 25772898
[8]	Chaudhuri A. Multiple sclerosis is primarily a neurodegenerative disease[J]. J Neural Transm (Vienna), 2013, 120(10):1463-1466.
[9]	Liddell J R. Are astrocytes the predominant cell type for activation of Nrf2 in aging and neurodegeneration?[J]. Antioxidants (Basel), 2017, 6(3):E65.
[10]	Islam M T. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders[J]. Neurol Res, 2017, 39(1):73-82. doi: 10.1080/01616412.2016.1251711
[11]	Haider L, Fischer M T, Frischer J M, et al. Oxidative damage in multiple sclerosis lesions[J]. Brain, 2011, 134(Pt 7):1914-1924. doi: 10.1093/brain/awr128 pmid: 21653539
[12]	Lim J L, Wilhelmus M M M, de Vries H E, et al. Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases[J]. Arch Toxicol, 2014, 88(10):1773-1786. doi: 10.1007/s00204-014-1338-z
[13]	Mahad D, Ziabreva I, Lassmann H, et al. Mitochondrial defects in acute multiple sclerosis lesions[J]. Brain, 2008, 131(Pt 7):1722-1735. doi: 10.1093/brain/awn105 pmid: 18515320
[14]	Campbell G R, Ziabreva I, Reeve A K, et al. Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis[J]. Ann Neurol, 2011, 69(3):481-492. doi: 10.1002/ana.22109 pmid: 21446022
[15]	van Horssen J, Schreibelt G, Drexhage J, et al. Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression[J]. Free Radic Biol Med, 2008, 45(12):1729-1737. doi: 10.1016/j.freeradbiomed.2008.09.023
[16]	Buendia I, Michalska P, Navarro E, et al. Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases[J]. Pharmacol Ther, 2016, 157:84-104. doi: 10.1016/j.pharmthera.2015.11.003
[17]	Ren H L, Lv C N, Xing Y, et al. Downregulated nuclear factor E2-related factor 2 (Nrf2) aggravates cognitive impairments via neuroinflammation and synaptic plasticity in the senescence-accelerated mouse prone 8 (SAMP8) mouse: a model of accelerated senescence[J]. Med Sci Monit, 2018, 24:1132-1144. doi: 10.12659/MSM.908954
[18]	Kim J, Cha Y N, Surh Y J. A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders[J]. Mutat Res, 2010, 690(1-2):12-23. doi: 10.1016/j.mrfmmm.2009.09.007
[19]	Gazaryan I G, Thomas B. The status of Nrf2-based therapeutics: current perspectives and future prospects[J]. Neural Regen Res, 2016, 11(11):1708-1711. doi: 10.4103/1673-5374.194706 pmid: 28123399
[20]	Niture S K, Khatri R, Jaiswal A K. Regulation of Nrf2–an update[J]. Free Radic Biol Med, 2014, 66:36-44. doi: 10.1016/j.freeradbiomed.2013.02.008
[21]	Canning P, Sorrell F J, Bullock A N. Structural basis of Keap1 interactions with Nrf2[J]. Free Radic Biol Med, 2015, 88(Pt B):101-107. doi: 10.1016/j.freeradbiomed.2015.05.034
[22]	Suzuki T, Yamamoto M. Molecular basis of the Keap1-Nrf2 system[J]. Free Radic Biol Med, 2015, 88(Pt B):93-100. doi: 10.1016/j.freeradbiomed.2015.06.006
[23]	Hu R, Saw C L, Yu R, et al. Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: antioxidant coupled with antiinflammatory[J]. Antioxid Redox Signal, 2010, 13(11):1679-1698. doi: 10.1089/ars.2010.3276
[24]	Keum Y S. Regulation of Nrf2-mediated phase II detoxification and anti-oxidant genes[J]. Biomol Ther (Seoul), 2012, 20(2):144-151. doi: 10.4062/biomolther.2012.20.2.144
[25]	Cullinan S B, Diehl J A. PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress[J]. J Biol Chem, 2004, 279(19):20108-20117. pmid: 14978030
[26]	Lu M C, Ji J A, Jiang Z Y, et al. The Keap1-Nrf2-ARE pathway as a potential preventive and therapeutic target: an update[J]. Med Res Rev, 2016, 36(5):924-963. doi: 10.1002/med.21396
[27]	Karkkainen V, Pomeshchik Y, Savchenko E, et al. Nrf2 regulates neurogenesis and protects neural progenitor cells against Abeta toxicity[J]. Stem Cells, 2014, 32(7):1904-1916. doi: 10.1002/stem.1666
[28]	van Muiswinkel F L, de Vos R A, Bol J G, et al. Expression of NAD(P)H: quinone oxidoreductase in the normal and Parkinsonian substantia nigra[J]. Neurobiol Aging, 2004, 25(9):1253-1262. pmid: 15312971
[29]	Gao Y, Chu S F, Li J P, et al. Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease[J]. Acta Pharmacol Sin, 2015, 36(3):311-322. doi: 10.1038/aps.2014.107
[30]	Chen M J Wong C H Y Peng Z F, et al. A global transcriptomic view of the multifaceted role of glutathione peroxidase-1 in cerebral ischemic-reperfusion injury[J]. Free Radic Biol Med, 2011, 50(6):736-748. doi: 10.1016/j.freeradbiomed.2010.12.025
[31]	Lisk C, Mccord J, Bose S, et al. Nrf2 activation: a potential strategy for the prevention of acute mountain sickness[J]. Free Radic Biol Med, 2013, 63:264-273. doi: 10.1016/j.freeradbiomed.2013.05.024
[32]	Kundu J K, Surh Y J. Nrf2-Keap1 signaling as a potential target for chemoprevention of inflammation-associated carcinogenesis[J]. Pharm Res, 2010, 27(6):999-1013. doi: 10.1007/s11095-010-0096-8
[33]	van Horssen J, Schreibelt G, Bo L, et al. NAD(P)H: quinone oxidoreductase 1 expression in multiple sclerosis lesions[J]. Free Radic Biol Med, 2006, 41(2):311-317. doi: 10.1016/j.freeradbiomed.2006.04.013
[34]	Ryter S W, Choi A M. Heme oxygenase-1/carbon monoxide: from metabolism to molecular therapy[J]. Am J Respir Cell Mol Biol, 2009, 41(3):251-260. doi: 10.1165/rcmb.2009-0170TR
[35]	Licht-Mayer S, Wimmer I, Traffehn S, et al. Cell type-specific Nrf2 expression in multiple sclerosis lesions[J]. Acta Neuropathologica, 2015, 130(2):263-277. doi: 10.1007/s00401-015-1452-x
[36]	Dringen R. Metabolism and functions of glutathione in brain[J]. Prog Neurobiol, 2000, 62(6):649-671. pmid: 10880854
[37]	Johnson D A, Amirahmadi S, Ward C, et al. The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis[J]. Toxicol Sci, 2010, 114(2):237-246. doi: 10.1093/toxsci/kfp274
[38]	Bernstein A I, Miller G W. Oxidative signaling in experimental autoimmune encephalomyelitis[J]. Toxicol Sci, 2010, 114(2):159-161. doi: 10.1093/toxsci/kfq012 pmid: 20234054
[39]	Linker R A, Lee D, Ryan S, et al. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway[J]. Brain, 2011, 134(3):678-692. doi: 10.1093/brain/awq386
[40]	Scannevin R H, Chollate S, Jung M Y, et al. Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway[J]. J Pharmacol Exp Ther, 2012, 341(1):274-284. doi: 10.1124/jpet.111.190132
[41]	Tutakhail A, Nazary Q A, Lebsir D, et al. Induction of brain Nrf2-HO-1 pathway and antinociception after different physical training paradigms in mice[J]. Life Sci, 2018, 209:149-156. doi: 10.1016/j.lfs.2018.08.004
[42]	Babayi Daylari T, Riazi G H, Pooyan S, et al. Influence of various intensities of 528 Hz sound-wave in production of testosterone in rat’s brain and analysis of behavioral changes[J]. Genes Genomics, 2019, 41(2):201-211. doi: 10.1007/s13258-018-0753-6
[43]	杜韬, 张威. 眼针八区八穴对急性脑梗死Keap1-Nrf2/ARE信号传导通路的影响[J]. 中华中医药学刊, 2018, 36(8):1837-1840.
[44]	Boyanapalli S S, Paredes-Gonzalez X, Fuentes F, et al. Nrf2 knockout attenuates the anti-inflammatory effects of phenethyl isothiocyanate and curcumin[J]. Chem Res Toxicol, 2014, 27(12):2036-2043. doi: 10.1021/tx500234h pmid: 25387343
[45]	Holloway P M, Gillespie S, Becker F, et al. Sulforaphane induces neurovascular protection against a systemic inflammatory challenge via both Nrf2-dependent and independent pathways[J]. Vascul Pharmacol, 2016, 85:29-38. doi: 10.1016/j.vph.2016.07.004
[46]	Turley A E, Zagorski J W, Rockwell C E. The Nrf2 activator tBHQ inhibits T cell activation of primary human CD4 T cells[J]. Cytokine, 2015, 71(2):289-295. doi: 10.1016/j.cyto.2014.11.006
[47]	Souza P S, Gonçalves E D, Pedroso G S, et al. Physical exercise attenuates experimental autoimmune encephalomyelitis by inhibiting peripheral immune response and blood-brain barrier disruption[J]. Mol Neurobiol, 2017, 54(6):4723-4737. doi: 10.1007/s12035-016-0014-0

Role of Kelch-like ECH-associated Protein-1-Nuclear Factor Erythroid 2-related Factor-2/Antioxidant Responsive Element Signal Pathway for Multiple Sclerosis (review)

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 47

Related Articles 15

Metrics

Comments

Recommended 0

[1]	SHAO Weiting, LEI Jianghua. Effect of response interruption and redirection as a behavioral intervention on vocal stereotypy in children with autism spectrum disorder: a scoping review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2024, 30(1): 10-20.
[2]	WANG Hangyu, GE Keke, FAN Yonghong, DU Lilu, ZOU Min, FENG Lei. Effect of active music therapy on cognitive function for older adults with cognitive impairment: a systematic review based on ICD-11 and ICF [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2024, 30(1): 36-43.
[3]	WEN Jianing, JIN Qiuyan, ZHANG Qi, LI Jie, SI Qi. Effect of cognitively engaging physical activity on developing executive function of children and adolescents: a systematic review based on ICF [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2024, 30(1): 44-53.
[4]	GE Keke, FAN Yonghong, WANG Hangyu, DU Lilu, LI Changjiang, ZOU Min. Health benefit of mindfulness intervention for older adults with insomnia disorders: a systematic review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2024, 30(1): 54-60.
[5]	ZHANG Jingya, ZOU Min, SUN Hongwei, SUN Changlong, ZHU Juntong. Effect of psychological intervention on anxiety or depression in children and adolescents with hearing impairment: a systematic review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(9): 1004-1011.
[6]	WANG Junyu, YANG Yong, YUAN Xun, XIE Ting, ZHUANG Jie. Effect of high-intensity interval training on executive function for healthy children and adolescents: a systematic review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(9): 1012-1020.
[7]	WEI Xiaowei, YANG Jian, WEI Chunyan. Psychological and behavioral benefits of adapted yoga exercise for children with autism spectrum disorder in special education schools: a systematic review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(9): 1021-1028.
[8]	YANG Yaru, YANG Jian. School-based physical activity-related health services and their health benefits within the World Health Organization health-promoting school framework: a systematic review of systematic reviews [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(9): 1040-1047.
[9]	WANG He, HAN Liang, KAN Mengfan, YU Shaohong. Efficacy of electrical stimulation on shoulder-hand syndrome after stroke: a systematic review and meta-analysis [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(9): 1048-1056.
[10]	SHI Jiawei, LI Lingyu, YANG Haojie, WANG Qinlu, ZOU Haiou. Effect of preoperative prerehabilitation training on total knee arthroplasty: a systematic review of systematic reviews [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(9): 1057-1064.
[11]	JIANG Changhao, HUANG Chen, GAO Xiaoyan, DAI Yuanfu, ZHAO Guoming. Effect of neurofeedback training on cognitive function in the elderly: a systematic review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(8): 903-909.
[12]	WEI Xiaowei, YANG Jian, WEI Chunyan, HE Qiling. Adapted physical education programs for psychomotor development in school settings for children with intellectual and developmental disabilities: a systematic review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(8): 910-918.
[13]	ZHANG Yuan, YANG Jian. School health services and effectiveness based on World Health Organization health-promoting school framework: a scoping review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(7): 791-799.
[14]	WANG Shaopu, CHEN Gang. Psychological-behavioral health services and its outcome based on World Health Organization health-promoting school framework: a systematic review of systematic reviews [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(7): 800-807.
[15]	JIANG Changhao, GAO Xiaoyan. Effect of acute physical activity on cognitive function in children: a systematic review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(6): 667-672.